Phosphagenics developing novel antipain patches; Transdermal drug delivery market poised for growth

> After announcing a $19.2M capital raising, Phosphagenics ($PPGNY) said in an update that it is developing a novel Oxymorphone patch and a Oxycodone patch to treat chronic pain. Release

> EastGate Acquisitions announced that it will expand its efforts to treat diabetes with the development of large-molecule drugs. The company will use its submicron platform technology. More

> The growth of the transdermal drug delivery market will continue at a CAGR of 9.92% over a 5-year period, according to TechNavio analysts. Report

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.